Verve Therapeutics Inc
NASDAQ:VERV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Verve Therapeutics Inc
NASDAQ:VERV
|
US |
|
Chunghwa Telecom Co Ltd
TWSE:2412
|
TW |
|
AirIQ Inc
XTSX:IQ
|
CA |
|
S
|
SCB X PCL
SET:SCB
|
TH |
|
I
|
Idaho Strategic Resources Inc
AMEX:IDR
|
US |
|
Danone SA
OTC:DANOY
|
FR |
|
Crimson Wine Group Ltd
OTC:CWGL
|
US |
|
Rentokil Initial PLC
LSE:RTO
|
UK |
|
A
|
Avenue Supermarts Ltd
BSE:540376
|
IN |
|
C
|
Compagnie d'entreprises CFE SA
XBRU:CFEB
|
BE |
|
Impala Platinum Holdings Ltd
OTC:IMPUF
|
ZA |
|
US Gold Corp
NASDAQ:USAU
|
US |
|
California Resources Corp
NYSE:CRC
|
US |
|
G
|
Great Pacific Gold Corp
XTSX:GPAC
|
CA |
|
CJ Corp
KRX:001040
|
KR |
|
Advanced Energy Industries Inc
NASDAQ:AEIS
|
US |
|
B
|
Biomarin Pharmaceutical Inc
XBER:BM8
|
US |
|
N
|
NWS Holdings Ltd
OTC:NWSZF
|
HK |
|
V
|
Vale SA
F:CVLB
|
BR |
|
Air Canada
TSX:AC
|
CA |
|
Brainchip Holdings Ltd
ASX:BRN
|
AU |
|
C
|
Comstock Inc
AMEX:LODE
|
US |
|
Coeur Mining Inc
NYSE:CDE
|
US |
|
Silicon Motion Technology Corp
NASDAQ:SIMO
|
TW |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VERV's stock price target?
Not Available
VERV does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Verve Therapeutics Inc?
Projected CAGR
-18%
The compound annual growth rate for Revenue over the next 3 years is -18%.